Biology:Gamma secretase
Gamma-secretase (Nicastrin subunit) | |||||||||
---|---|---|---|---|---|---|---|---|---|
![]() | |||||||||
Identifiers | |||||||||
Symbol | Gamma-secretase, γ-secretase | ||||||||
Pfam | PF05450 | ||||||||
InterPro | IPR008710 | ||||||||
OPM superfamily | 244 | ||||||||
OPM protein | [ 5fn5[ | ||||||||
Membranome | 155 | ||||||||
|
Gamma secretase is a multi-subunit protease complex, itself an integral membrane protein, that cleaves single-pass transmembrane proteins at residues within the transmembrane domain. Proteases of this type are known as intramembrane proteases. The most well-known substrate of gamma secretase is amyloid precursor protein, a large integral membrane protein that, when cleaved by both gamma and beta secretase, produces a short 37-43[verification needed] amino acid peptide called amyloid beta whose abnormally folded fibrillar form is the primary component of amyloid plaques found in the brains of Alzheimer's disease patients. Gamma secretase is also critical in the related processing of several other type I integral membrane proteins, such as Notch,[1] ErbB4,[2] E-cadherin,[3] N-cadherin,[4] ephrin-B2,[5] or CD44.[6]
Subunits and assembly
The gamma secretase complex consists of four individual proteins: PSEN1 (presenilin-1),[7] nicastrin, APH-1 (anterior pharynx-defective 1), and PEN-2 (presenilin enhancer 2).[8] Recent evidence suggests that a fifth protein, known as CD147, is a non-essential regulator of the complex whose absence increases activity.[9][10] Presenilin, an aspartyl protease, is the catalytic subunit; mutations in the presenilin gene have been shown to be a major genetic risk factor for Alzheimer's disease [11] and modulates immune cell activity.[12] In humans, two forms of presenilin and two forms of APH-1 have been identified in the genome; one of the APH homologs can also be expressed in two isoforms via alternative splicing, leading to at least six different possible gamma secretase complexes that may have tissue- or cell type specificity.[13]
The proteins in the gamma secretase complex are heavily modified by proteolysis during assembly and maturation of the complex; a required activation step is in the autocatalytic cleavage of presenilin to N- and C-terminal fragments. Nicastrin's primary role is in maintaining the stability of the assembled complex and regulating intracellular protein trafficking.[14] PEN-2 associates with the complex via binding of a transmembrane domain of presenilin[15] and, among other possible roles, helps to stabilize the complex after presenilin proteolysis has generated the activated N-terminal and C-terminal fragments.[16] APH-1, which is required for proteolytic activity, binds to the complex via a conserved alpha helix interaction motif and aids in initiating assembly of premature components.[17]
Recent research has shown that interaction of the gamma secretase complex with the γ-secretase activating protein facilitates the gamma cleavage of amyloid precursor protein into β-amyloid.[18]
Cellular trafficking
The gamma secretase complex is thought to assemble and mature via proteolysis in the early endoplasmic reticulum.[19] The complexes are then transported to the late ER where they interact with and cleave their substrate proteins.[20] Gamma secretase complexes have also been observed localized to the mitochondria, where they may play a role in promoting apoptosis.[21]
Function
Gamma secretase is an internal protease that cleaves within the membrane-spanning domain of its substrate proteins, including amyloid precursor protein (APP) and Notch. Substrate recognition occurs via nicastrin ectodomain binding to the N-terminus of the target, which is then passed via a poorly understood process between the two presenilin fragments to a water-containing active site where the catalytic aspartate residue is located. The active site must contain water to carry out hydrolysis within a hydrophobic environment in the interior of the cell membrane, although it is not well understood how water and proton exchange is effected, and as yet no X-ray crystallography structure of gamma secretase is available.[22] Low-resolution electron microscopy reconstructions have allowed the visualization of the hypothesized internal pores of about 2 nanometres.[23] In 2014, a three-dimensional structure of an intact human gamma-secretase complex was determined by cryo-electron microscopy single-particle analysis at 4.5 angstrom resolution[24] and in 2015 an atomic-resolution (3.4 angstrom) cryo-EM structure was reported.[25]
The gamma secretase complex is unusual among proteases in having a "sloppy" cleavage site at the C-terminal site in amyloid beta generation; gamma secretase can cleave APP in any of multiple sites to generate a peptide of variable length, most typically from 39 to 42 amino acids long, with Aβ40 the most common isoform and Aβ42 the most susceptible to conformational changes leading to amyloid fibrillogenesis. Certain mutations in both APP and in both types of human presenilin are associated with increased Aβ42 production and the early-onset genetic form of familial Alzheimer's disease.[26] Although older data suggested that different forms of the gamma secretase complex could be differentially responsible for generating different amyloid beta isoforms,[27] current evidence indicates that the C-terminus of amyloid beta is produced by a series of single-residue cleavages by the same gamma secretase complex.[28][29][30] Earlier cleavage sites produce peptides of length 46 (zeta-cleavage) and 49 (epsilon-cleavage).[29]
See also
- DAPT (chemical), a γ-secretase inhibitor
References
- ↑ "A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain". Nature 398 (6727): 518–22. 1999. doi:10.1038/19083. PMID 10206645.
- ↑ "gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase". Science 294 (5549): 2179–81. 2001. doi:10.1126/science.1065412. PMID 11679632.
- ↑ "A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions". EMBO J 21 (8): 1948–56. 2002. doi:10.1093/emboj/21.8.1948. PMID 11953314.
- ↑ "A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations". Cell 114 (5): 635–45. 2003. doi:10.1016/j.cell.2003.08.008. PMID 13678586.
- ↑ "Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling". EMBO J 25 (6): 1242–52. 2006. doi:10.1038/sj.emboj.7601031. PMID 16511561.
- ↑ "Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide". J Biol Chem 277 (47): 44754–9. 2002. doi:10.1074/jbc.M206872200. PMID 12223485.
- ↑ Sobhanifar, S; Schneider, B; Löhr, F; Gottstein, D; Ikeya, T; Mlynarczyk, K; Pulawski, W; Ghoshdastider, U et al. (25 May 2010). "Structural investigation of the C-terminal catalytic fragment of presenilin 1.". Proceedings of the National Academy of Sciences of the United States of America 107 (21): 9644–9. doi:10.1073/pnas.1000778107. PMID 20445084.
- ↑ "Assembly, trafficking and function of gamma-secretase". Neurodegener Dis 3 (4–5): 275–83. 2006. doi:10.1159/000095267. PMID 17047368. https://epub.ub.uni-muenchen.de/16592/1/10_1159_000095267.pdf.
- ↑ "The discovery and role of CD147 as a subunit of gamma-secretase complex". Drug News Perspect. 19 (3): 133–8. April 2006. doi:10.1358/dnp.2006.19.3.985932. PMID 16804564.
- ↑ "CD147 is a regulatory subunit of the γ-secretase complex in Alzheimer's disease amyloid β-peptide production". Proc. Natl. Acad. Sci. U.S.A. 102 (21): 7499–504. May 2005. doi:10.1073/pnas.0502768102. PMID 15890777.
- ↑ "TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity". Nature 440 (7088): 1208–12. April 2006. doi:10.1038/nature04667. PMID 16641999.
- ↑ "g secretase component presenilin is important for microglia b-Amyloid clearance". Annals of Neurology 69 (1): 170–80. November 2010. doi:10.1002/ana.22191. PMID 21280087.
- ↑ Shirotani, K; Edbauer, D; Prokop, S; Haass, C; Steiner, H. (2004). "Identification of distinct gamma-secretase complexes with different APH-1 variants". J Biol Chem 279 (40): 41340–5. doi:10.1074/jbc.M405768200. PMID 15286082.
- ↑ "Nicastrin Is Critical for Stability and Trafficking but Not Association of Other Presenilin/γ-Secretase Components". J. Biol. Chem. 280 (17): 17020–6. April 2005. doi:10.1074/jbc.M409467200. PMID 15711015.
- ↑ "Pen-2 is incorporated into the gamma-secretase complex through binding to transmembrane domain 4 of presenilin 1". J. Biol. Chem. 280 (51): 41967–75. December 2005. doi:10.1074/jbc.M509066200. PMID 16234244.
- ↑ "Requirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the gamma-secretase complex". J. Biol. Chem. 279 (22): 23255–61. May 2004. doi:10.1074/jbc.M401789200. PMID 15039426.
- ↑ "A conserved GXXXG motif in APH-1 is critical for assembly and activity of the gamma-secretase complex". J. Biol. Chem. 279 (6): 4144–52. February 2004. doi:10.1074/jbc.M309745200. PMID 14627705.
- ↑ "Gamma-secretase activating protein, a therapeutic target for Alzheimer's disease". Nature 467 (2): 95–98. September 2010. doi:10.1038/nature09325. PMID 20811458.
- Gina Kolata (September 1, 2010). "Finding Suggests New Aim for Alzheimer's Drugs". The New York Times. https://www.nytimes.com/2010/09/02/health/research/02alzheimer.html.
- ↑ "Gamma-secretase complex assembly within the early secretory pathway". J. Biol. Chem. 280 (8): 6471–8. February 2005. doi:10.1074/jbc.M409106200. PMID 15591316.
- ↑ "Evidence that assembly of an active gamma-secretase complex occurs in the early compartments of the secretory pathway". J. Biol. Chem. 279 (47): 48615–9. November 2004. doi:10.1074/jbc.C400396200. PMID 15456788.
- ↑ "Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria". J. Biol. Chem. 279 (49): 51654–60. December 2004. doi:10.1074/jbc.M404500200. PMID 15456764.
- ↑ Wolfe MS (July 2006). "The gamma-secretase complex: membrane-embedded proteolytic ensemble". Biochemistry 45 (26): 7931–9. doi:10.1021/bi060799c. PMID 16800619.
- ↑ "Electron microscopic structure of purified, active γ-secretase reveals an aqueous intramembrane chamber and two pores". Proc. Natl. Acad. Sci. U.S.A. 103 (18): 6889–94. May 2006. doi:10.1073/pnas.0602321103. PMID 16636269.
- ↑ "Three-dimensional structure of human γ-secretase". Nature 512 (7513): 166–170. August 2014. doi:10.1038/nature13567. PMID 25043039.
- ↑ Cite error: Invalid
<ref>
tag; no text was provided for refs namedbai
- ↑ "Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment". J. Neurochem. 94 (5): 1189–201. September 2005. doi:10.1111/j.1471-4159.2005.03266.x. PMID 15992373.
- ↑ "Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase". Hum. Mol. Genet. 13 (2): 159–70. January 2004. doi:10.1093/hmg/ddh019. PMID 14645205.
- ↑ "The same gamma-secretase accounts for the multiple intramembrane cleavages of APP". J. Neurochem. 100 (5): 1234–46. March 2007. doi:10.1111/j.1471-4159.2006.04302.x. PMID 17241131.
- ↑ 29.0 29.1 Zhang, H; Ma, Q; Zhang, YW; Xu, H (January 2012). "Proteolytic processing of Alzheimer's β-amyloid precursor protein.". Journal of Neurochemistry 120 Suppl 1: 9–21. doi:10.1111/j.1471-4159.2011.07519.x. PMID 22122372.
- ↑ Haass, C; Kaether, C; Thinakaran, G; Sisodia, S (May 2012). "Trafficking and proteolytic processing of APP.". Cold Spring Harbor Perspectives in Medicine 2 (5): a006270. doi:10.1101/cshperspect.a006270. PMID 22553493.
![]() | Original source: https://en.wikipedia.org/wiki/Gamma secretase.
Read more |